List of Tables
Table 1. Neutropenia Biologic Drug Treatment Market Trends
Table 2. Neutropenia Biologic Drug Treatment Market Drivers & Opportunity
Table 3. Neutropenia Biologic Drug Treatment Market Challenges
Table 4. Neutropenia Biologic Drug Treatment Market Restraints
Table 5. Global Neutropenia Biologic Drug Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Neutropenia Biologic Drug Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Neutropenia Biologic Drug Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Neutropenia Biologic Drug Treatment
Table 10. Global Neutropenia Biologic Drug Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neutropenia Biologic Drug Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Neutropenia Biologic Drug Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Neutropenia Biologic Drug Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Neutropenia Biologic Drug Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Neutropenia Biologic Drug Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Neutropenia Biologic Drug Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Neutropenia Biologic Drug Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Neutropenia Biologic Drug Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Neutropenia Biologic Drug Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Neutropenia Biologic Drug Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Neutropenia Biologic Drug Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Neutropenia Biologic Drug Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Neutropenia Biologic Drug Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Neutropenia Biologic Drug Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Neutropenia Biologic Drug Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Neutropenia Biologic Drug Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Neutropenia Biologic Drug Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Neutropenia Biologic Drug Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Neutropenia Biologic Drug Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Teva Pharmaceutical Basic Information List
Table 32. Teva Pharmaceutical Description and Business Overview
Table 33. Teva Pharmaceutical Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of Teva Pharmaceutical (2019-2024)
Table 35. Teva Pharmaceutical Recent Developments
Table 36. Amgen Basic Information List
Table 37. Amgen Description and Business Overview
Table 38. Amgen Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of Amgen (2019-2024)
Table 40. Amgen Recent Developments
Table 41. Sanofi Basic Information List
Table 42. Sanofi Description and Business Overview
Table 43. Sanofi Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of Sanofi (2019-2024)
Table 45. Sanofi Recent Developments
Table 46. Mylan(Fulphila) Basic Information List
Table 47. Mylan(Fulphila) Description and Business Overview
Table 48. Mylan(Fulphila) Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of Mylan(Fulphila) (2019-2024)
Table 50. Mylan(Fulphila) Recent Developments
Table 51. Kyowa Kirin Basic Information List
Table 52. Kyowa Kirin Description and Business Overview
Table 53. Kyowa Kirin Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of Kyowa Kirin (2019-2024)
Table 55. Kyowa Kirin Recent Developments
Table 56. Novartis Basic Information List
Table 57. Novartis Description and Business Overview
Table 58. Novartis Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of Novartis (2019-2024)
Table 60. Novartis Recent Developments
Table 61. Spectrum Pharmaceuticals Basic Information List
Table 62. Spectrum Pharmaceuticals Description and Business Overview
Table 63. Spectrum Pharmaceuticals Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of Spectrum Pharmaceuticals (2019-2024)
Table 65. Spectrum Pharmaceuticals Recent Developments
Table 66. Pfizer Basic Information List
Table 67. Pfizer Description and Business Overview
Table 68. Pfizer Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of Pfizer (2019-2024)
Table 70. Pfizer Recent Developments
Table 71. Baxter International Basic Information List
Table 72. Baxter International Description and Business Overview
Table 73. Baxter International Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of Baxter International (2019-2024)
Table 75. Baxter International Recent Developments
Table 76. Partner Therapeutics(Leukine) Basic Information List
Table 77. Partner Therapeutics(Leukine) Description and Business Overview
Table 78. Partner Therapeutics(Leukine) Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of Partner Therapeutics(Leukine) (2019-2024)
Table 80. Partner Therapeutics(Leukine) Recent Developments
Table 81. BeyondSpring Pharmaceuticals Basic Information List
Table 82. BeyondSpring Pharmaceuticals Description and Business Overview
Table 83. BeyondSpring Pharmaceuticals Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of BeyondSpring Pharmaceuticals (2019-2024)
Table 85. BeyondSpring Pharmaceuticals Recent Developments
Table 86. Cellerant Therapeutics Basic Information List
Table 87. Cellerant Therapeutics Description and Business Overview
Table 88. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of Cellerant Therapeutics (2019-2024)
Table 90. Cellerant Therapeutics Recent Developments
Table 91. Enzychem Lifesciences Corporation Basic Information List
Table 92. Enzychem Lifesciences Corporation Description and Business Overview
Table 93. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 94. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of Enzychem Lifesciences Corporation (2019-2024)
Table 95. Enzychem Lifesciences Corporation Recent Developments
Table 96. Myelo Therapeutics Basic Information List
Table 97. Myelo Therapeutics Description and Business Overview
Table 98. Myelo Therapeutics Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 99. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of Myelo Therapeutics (2019-2024)
Table 100. Myelo Therapeutics Recent Developments
Table 101. Generon Basic Information List
Table 102. Generon Description and Business Overview
Table 103. Generon Neutropenia Biologic Drug Treatment Products, Services and Solutions
Table 104. Revenue (US$ Million) in Neutropenia Biologic Drug Treatment Business of Generon (2019-2024)
Table 105. Generon Recent Developments
Table 106. Key Raw Materials Lists
Table 107. Raw Materials Key Suppliers Lists
Table 108. Neutropenia Biologic Drug Treatment Downstream Customers
Table 109. Neutropenia Biologic Drug Treatment Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Neutropenia Biologic Drug Treatment Product Picture
Figure 2. Global Neutropenia Biologic Drug Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Neutropenia Biologic Drug Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Neutropenia Biologic Drug Treatment Report Years Considered
Figure 5. Global Neutropenia Biologic Drug Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Neutropenia Biologic Drug Treatment Revenue in 2023
Figure 7. Neutropenia Biologic Drug Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Filgrastim Picture
Figure 9. Pegfilgrastim Picture
Figure 10. Lenograstim Picture
Figure 11. Lipegfilgrastim Picture
Figure 12. Sargramostim Picture
Figure 13. Global Neutropenia Biologic Drug Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Neutropenia Biologic Drug Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Retail Pharmacies
Figure 16. Product Picture of Hospital Pharmacies
Figure 17. Product Picture of Online Pharmacies
Figure 18. Global Neutropenia Biologic Drug Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Neutropenia Biologic Drug Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Neutropenia Biologic Drug Treatment Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Neutropenia Biologic Drug Treatment Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Neutropenia Biologic Drug Treatment Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Neutropenia Biologic Drug Treatment Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Neutropenia Biologic Drug Treatment Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Neutropenia Biologic Drug Treatment Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Neutropenia Biologic Drug Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Neutropenia Biologic Drug Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Neutropenia Biologic Drug Treatment Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Neutropenia Biologic Drug Treatment Sales Value (%), (2019-2030)
Figure 31. United States Neutropenia Biologic Drug Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Neutropenia Biologic Drug Treatment Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Neutropenia Biologic Drug Treatment Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Neutropenia Biologic Drug Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Neutropenia Biologic Drug Treatment Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Neutropenia Biologic Drug Treatment Sales Value by Application (%), 2023 VS 2030
Figure 37. China Neutropenia Biologic Drug Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Neutropenia Biologic Drug Treatment Sales Value by Type (%), 2023 VS 2030
Figure 39. China Neutropenia Biologic Drug Treatment Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Neutropenia Biologic Drug Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Neutropenia Biologic Drug Treatment Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Neutropenia Biologic Drug Treatment Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Neutropenia Biologic Drug Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Neutropenia Biologic Drug Treatment Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Neutropenia Biologic Drug Treatment Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Neutropenia Biologic Drug Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Neutropenia Biologic Drug Treatment Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Neutropenia Biologic Drug Treatment Sales Value by Application (%), 2023 VS 2030
Figure 49. India Neutropenia Biologic Drug Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Neutropenia Biologic Drug Treatment Sales Value by Type (%), 2023 VS 2030
Figure 51. India Neutropenia Biologic Drug Treatment Sales Value by Application (%), 2023 VS 2030
Figure 52. Neutropenia Biologic Drug Treatment Industrial Chain
Figure 53. Neutropenia Biologic Drug Treatment Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
